New guidance on prescribing opioids unveiled Thursday by the Centers for Disease Control and Prevention avoids the strict limits found in a 2016 version that accelerated a nationwide drop in pain pill prescriptions but led to backlash from chronic pain patients.
The 229-page document advises doctors to limit new opioid prescriptions and discuss alternative therapies with patients. But the new guidance largely avoids figures on dosage and length of prescription and warns against abruptly or rapidly discontinuing pain pills for some chronic pain patients.
"We've built in flexibility so that there's not a one-size-fits-all approach," said Christopher Jones, acting director of the CDC's National Center for Injury Prevention and Control.
Vinay Prasad, a top vaccine regulator ousted from the Food and Drug Administration (FDA) late last...
A federal judge blocked enforcement of a provision in President Donald Trump's recently enacted tax and...
Health Secretary Robert F. Kennedy Jr. signed a controversial recommendation July 23 from a vaccine panel...
